Log in
Enquire now
‌

US Patent 10940300 Medicament applicator

Patent 10940300 was granted and assigned to Kashiv Pharma Llc on March, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Kashiv Pharma Llc
Current Assignee
‌
Kashiv Pharma Llc
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10940300
Date of Patent
March 9, 2021
Patent Application Number
15888330
Date Filed
February 5, 2018
Patent Citations Received
‌
US Patent 12076519 Drug delivery device and methods having a retaining member
0
‌
US Patent 11759614 Enhanced stylet for drug depot injector
‌
US Patent 12017050 Drug depot delivery system and method
0
Patent Primary Examiner
‌
Manuel A Mendez
Patent abstract

Apparatus and methods for inserting a medicament into a body cavity are described. The apparatus comprises an elongate tube with a plunger rod therein. The plunger rod has at least one projection which cooperatively interacts or engages with at least one discontinuity on the inside of the elongate tube so that proximal movement of the plunger rod with respect to the elongate tube expels the medicament into the body cavity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10940300 Medicament applicator

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.